ENVERIC BIOSCIENCES, INC. Loss Contingency, Estimate of Possible Loss
ENVERIC BIOSCIENCES, INC. (ENVB) had Loss Contingency, Estimate of Possible Loss of $3.00 million as of 2020-01-30, per its 10-K/A filed 2020-08-12.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LossContingencyEstimateOfPossibleLoss · last filed 2020-08-12
- 2020-01-30: Loss Contingency, Estimate of Possible Loss $3.00M.
| Period end | Loss Contingency, Estimate of Possible Loss |
|---|---|
| 2020-01-30 | $3.00M 10-K/A · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |